Gilead Sciences (NASDAQ:GILD)

Major Biotechs Send Short Sellers Running for Cover

The short interest data are out for the most recent settlement date, July 31. Generally speaking, companies within the biotech industry are considered to be a riskier group of stocks, ...
Read Full Story »

Analyst Has Top Biotech Stocks to Buy as Sector Stays Red Hot

After a wretched 2016, when many of the top biotech companies were hit hard by campaign rhetoric, the industry has roared back to life this year. While nowhere near the ...
Read Full Story »

Short Sellers Run for Cover From Major Biotech Stocks

The short interest data are out for the most recent settlement date, July 14. Generally speaking, companies within the biotech industry are considered to be a riskier group of stocks, ...
Read Full Story »

Gilead Secures FDA Approval For Chronic Hepatitis C Re-Treatment

Gilead Sciences, Inc. (NASDAQ: GILD) shares remained unchanged after the firm announced an approval from the U.S. Food and Drug Administration (FDA). Essentially, the FDA approved Vosevi (sofosbuvir 400 mg/velpatasvir ...
Read Full Story »

Short Sellers Hike Bets in Major Biotechs

The short interest data are out for the most recent settlement date, June 30. Generally speaking, companies within the biotech industry are considered to be a riskier group of stocks, ...
Read Full Story »

Meet Jefferies Top 12 Picks in the Roaring Biotech Industry

The biotech industry has made a splash in 2017, outperforming practically all the broad markets. With this incredible display, it's no wonder that investor interest in this particular industry has ...
Read Full Story »

Analyst Predicts Major Short Squeeze in 4 Biotech Stocks to Buy

If any industry has done a head-spinning turnaround recently it was biotechnology. Last week saw the Nasdaq Biotech Index spike up almost 9%. While some was given back so far ...
Read Full Story »

Major Biotech Short Interest Surges

The short interest data are out for the most recent settlement date, June 15. Generally speaking, companies within the biotech industry are considered to be a riskier group of stocks, ...
Read Full Story »

Top Analyst Upgrades and Downgrades: AK Steel, Altice USA, Biogen, Caterpillar, Gilead, Oracle and Many More

Stocks have recently hit all-time highs again, but the stock indexes seem to have gone sideways in recent days and they were looking for direction on a slow news Friday. ...
Read Full Story »

Short Interest Surges in Major Biotechs

The short interest data are out for the most recent settlement date, May 31. Generally speaking, companies within the biotech industry are considered to be a riskier group of stocks, ...
Read Full Story »

Short Sellers Raise the Stakes in Major Biotechs

The short interest data are out for the most recent settlement date, May 15. Generally speaking, companies within the biotech industry are considered to be a riskier group of stocks, ...
Read Full Story »

Why Big Pharma Is Not at Fault for Record Drug Spending

With prescription drug spending breaking new records almost every year now, people like to blame Big Pharma and use it as the industry punching bag. But the truth is, Big ...
Read Full Story »

Major Biotech Short Interest Remains Mixed

The short interest data are out for the most recent settlement date, April 28. Generally speaking, companies within the biotech industry are considered to be a riskier group of stocks, ...
Read Full Story »

Gilead Faces Serious Conundrum: Value Trap vs Real Value

Gilead Sciences Inc. (NASDAQ: GILD) had perhaps become the greatest biotech growth story of all time. In a world that only rewards what you will do next rather than what ...
Read Full Story »

Value or Value Trap: Meet the 21 S&P 500 Stocks Valued Under 10 Times Earnings

The bull market is now well over eight years old, and investors are looking for new ideas for how they should be investing their money. Stocks, bonds and commodities are all ...
Read Full Story »